Sign in
CompletedNo phase

Effect of a Hybrid Rehabilitation Program on Walking, Quality of Life & Cardiovascular Risk in People With PAD

Key facts

Who runs it
Ottawa Heart Institute Research Corporation
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
26 people enrolled
Started
9 Jul 2019
Ended
1 Oct 2024
Type of study
Observational
Treatments tested
  • HY-PAD
Record updated
6 May 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Intermittent claudication with PAD documented by:; ABI ≤0.90 or >1.40;(14) or; Anatomic evidence of lower extremity arterial stenosis ≥50% (by lower extremity angiography, CT angiography, MR angiography or ultrasound)
  • Ability to participate in the study (ability to walk)
  • Willingness to provide informed consent

Who cannot take part

  • They have had previous lower extremity amputation
  • They are unable to walk
  • They have critical limb ischemia or open lower extremity wounds
  • Patient is unable to read and understand English or French
  • Patient is unable, in the opinion of the qualified investigator or referring physician, to comprehend and participate in the exercise intervention

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Peripheral arterial disease (PAD), a disabling condition, affects 800,000 Canadians. People with PAD suffer from poor quality of life due to leg pain, which makes walking difficult. They also have a high risk of heart disease. In November of 2017, the University of Ottawa Heart Institute (UOHI) launched Canada's first specific walking rehabilitation and cardiovascular risk reduction program dedicated to patients with PAD.

Read full original descriptionShow less

An on-site, supervised exercise program to improve walking endurance and quality of life in PAD has been shown to be successful. However many patients are not able to participate in the on-site program due to barriers such as transportation, parking, or other commitments. Recently, a home-based walking program has also been shown to significantly improve walking endurance and quality of life among people with PAD. It was decided that a hybrid program, that has a short on-site program followed by a home-based program may allow more patients to participate and have the highest chance of success.

The goal is to develop a new hybrid program for medical care in PAD patients in order to: (a) improve their walking distance, (b) improve their quality of life and (c) improve their cardiovascular risk.

As part of this study the investigators will enrol 25 participants with PAD. Participants will be studied at baseline (before their first on-site class) and at 3 month follow up (after their last home program phone call).

Treatments tested

  • HY-PAD

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of a Hybrid Rehabilitation Program on Walking, Quality of Life and Cardiovascular Risk in People With Peripheral Arterial Disease (HY-PAD): A Pilot Randomized Controlled Trial
Record updated
6 May 2026